Works by Hammers, C.M.


Results: 8
    1
    2
    3

    Incidence of pemphigoid diseases in Northern Germany in 2016 – first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 5, p. 1197, doi. 10.1111/jdv.17107
    By:
    • Beek, N.;
    • Weidinger, A.;
    • Schneider, S.W.;
    • Kleinheinz, A.;
    • Gläser, R.;
    • Holtsche, M.M.;
    • Georg, A.;
    • Hammers, C.M.;
    • Hübner, F.;
    • Lima, A.‐L.;
    • Gola, D.;
    • Sadik, C.D.;
    • Zillikens, D.;
    • Katalinic, A.;
    • Schmidt, E.;
    • König, I.R.
    Publication type:
    Article
    4

    Long‐term outcomes of rituximab therapy in pemphigus.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 12, p. 2884, doi. 10.1111/jdv.16561
    By:
    • Shimanovich, I.;
    • Baumann, T.;
    • Schmidt, E.;
    • Zillikens, D.;
    • Hammers, C.M.
    Publication type:
    Article
    5
    6
    7
    8